Related content

Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449–450

By Sumnall H.   Jerome L.   Doblin R.   Mithoefer M.  

Psychopharmacology, Vol. 171, Iss. 2, 2004-01 ,pp. : 229-230

Springer Publishing Company

Access to resources Recommend Favorite

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

By Parrott Andy   Milani Raffaella   Parmar Rishee   Turner John  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 77-82

Springer Publishing Company

Access to resources Recommend Favorite

Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 272-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self-Reported Physical, Affective and Somatic Effects of Ecstasy (MDMA): An Observational Study of Recreational Users

By  

Current Psychopharmacology, Vol. 6, Iss. 1, 2017-04 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 199-207

John Wiley & Sons Inc

Access to resources Recommend Favorite